HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of acute bleeding in a patient with congenital afibrinogenaemia.

Abstract
Congenital afibrinogenaemia is a rare bleeding disorder characterized by absence of fibrinogen and varying bleeding tendency. Treatment with fibrinogen concentrates is considered to be the best choice for afibrinogenaemic patients who experience bleeding. We report the case of a 22-year-old Greek patient who presented with large muscular haematomas and was treated with fibrinogen concentrates. The efficacy of this treatment and the problems that arose during his hospitalization are being discussed.
AuthorsS Vakalopoulou, D Rizopoulou, E Zafiriadou, V Perifanis, K Tziomalos, E Lefkou, M Hill, G Dolan, V Garipidou
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 12 Issue 6 Pg. 676-8 (Nov 2006) ISSN: 1351-8216 [Print] England
PMID17083521 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Fibrinogen
Topics
  • Adult
  • Afibrinogenemia (complications)
  • Blood Coagulation Disorders
  • Fibrinogen (therapeutic use)
  • Hemorrhage (etiology, prevention & control)
  • Humans
  • Male
  • Rare Diseases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: